The pharmaceutical company Eli Lilly announced on Tuesday that it will build a $6.5 billion facility in Texas, marking the company’s second multibillion-dollar U.S. investment this month.
The Indiana-based company announced in February that it would be making four distinct manufacturing investments in 2025 across the United States, with the goal of bringing 13,000 domestic jobs to the American economy. Eli Lilly recently announced the first of these investments, with plans to build a $5 billion manufacturing facility in Goochland County, Virginia, on Sept. 16.
The facility in Texas will be dedicated to producing the company’s first GLP-1 pill, orforglipron, and is expected to bring 615 jobs to the Houston area. Eli Lilly’s CEO David A. Ricks said the Houston facility will help the company manufacture the pill “at scale.”
“This significant U.S. investment and…



